Park Ha Biological Technology (BYAH) Operating Leases (2023 - 2025)

Park Ha Biological Technology (BYAH) recorded quarterly Operating Leases of $75915.0 in Q4 2025, up 699.78% quarter-over-quarter from $9492.0 in Q4 2023.

Park Ha Biological Technology (BYAH) Operating Leases (2023 - 2025) Analysis & Trends

Park Ha Biological Technology's Operating Leases history runs 2 years deep, the most recent figure standing at $75915.0 for Q4 2025.

  • In Q4 2025, Operating Leases changed N/A year-over-year to $75915.0; the TTM figure through Oct 2025 stood at $75915.0 (changed N/A YoY), while the FY2025 annual figure was $75915.0, changed N/A from the prior year.
  • Operating Leases was $75915.0 for Q4 2025 at Park Ha Biological Technology, up from $9492.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $75915.0 in Q4 2025 to a low of $9492.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Tantech Holdings 587.03 Bn 587.00 Bn -
2 Procter & Gamble 346.82 Bn 334.74 Bn 10.51 Bn
3 Unilever 145.94 Bn 135.46 Bn -
4 Colgate Palmolive 70.39 Bn 69.40 Bn 3.23 Bn
5 Kenvue 34.34 Bn 34.23 Bn 2.30 Bn
6 Kimberly Clark 33.38 Bn 32.96 Bn 1.53 Bn
7 Estee Lauder Companies 31.47 Bn 28.34 Bn 2.84 Bn
8 Church & Dwight 22.92 Bn 22.42 Bn 681.40 Mn
9 Clorox 11.90 Bn 10.87 Bn 722.00 Mn
10 Park Ha Biological Technology 912,742.27 -2.87 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2025 75,915.00
Oct 31, 2023 9,492.00